Ali E. Canbay
Impact in
- Hepatology top 0.1%
- Liver Disease and Transplantation
- Liver physiology and pathology
- Hepatitis C virus research
- Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 143
- Liver Disease and Transplantation 71
- Liver Diseases and Immunity 24
- Liver physiology and pathology 23
- Epidemiology 186
- Liver Disease Diagnosis and Treatment 160
- Hepatitis B Virus Studies 23
- Co-authors
- Gregory James Gores (19 shared papers)Guido Gerken (145 shared papers)Ariel E. Feldstein (15 shared papers)Lars P. Bechmann (69 shared papers)Jan‐Peter Sowa (72 shared papers)Alexander Wree (15 shared papers)Steven F. Bronk (11 shared papers)Hajime Higuchi (10 shared papers)
- Journals
- Journal of Hepatology (25 papers)Digestion (19 papers)Liver International (18 papers)Hepatology (17 papers)PLoS ONE (12 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Ali E. Canbay
390 papers receiving 16.7k citations
Ali E. Canbay's Hit Papers
Peers
Comparison fields: 5 of 166
- Hepatology 4.9k
- Epidemiology 8.6k
- Pharmacology 1.2k
- Endocrinology, Diabetes and Metabolism 2.0k
- Cell Biology 1.4k
Countries citing papers authored by Ali E. Canbay
This map shows the geographic impact of Ali E. Canbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali E. Canbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali E. Canbay more than expected).
Fields of papers citing papers by Ali E. Canbay
This network shows the impact of papers produced by Ali E. Canbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali E. Canbay. The network helps show where Ali E. Canbay may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali E. Canbay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 423 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Hit paper breakdown → | 2003 | 928 |
| 2 | NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice Hit paper breakdown → | 2013 | 828 |
| 3 | The interaction of hepatic lipid and glucose metabolism in liver diseases Hit paper breakdown → | 2011 | 808 |
| 4 | Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway Hit paper breakdown → | 2004 | 696 |
| 5 | From NAFLD to NASH to cirrhosis—new insights into disease mechanisms Hit paper breakdown → | 2013 | 527 |
| 6 | Extrahepatic complications of nonalcoholic fatty liver disease Hit paper breakdown → | 2013 | 485 |
| 7 | 2004 | 449 | |
| 8 | 2010 | 430 | |
| 9 | NLRP3 inflammasome activation is required for fibrosis development in NAFLD Hit paper breakdown → | 2014 | 429 |
| 10 | 2003 | 404 | |
| 11 | 2003 | 358 | |
| 12 | 2003 | 282 | |
| 13 | 2014 | 269 | |
| 14 | 2002 | 260 | |
| 15 | 2019 | 218 | |
| 16 | 2013 | 202 | |
| 17 | 2002 | 194 | |
| 18 | 2004 | 185 | |
| 19 | 2010 | 180 | |
| 20 | 2003 | 173 |
About Ali E. Canbay
Ali E. Canbay is a scholar working on Hepatology, Epidemiology, Pharmacology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 423 papers that have together received 17.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (160 papers), Liver Disease and Transplantation (71 papers), Drug-Induced Hepatotoxicity and Protection (32 papers), Diet, Metabolism, and Disease (32 papers), Liver Diseases and Immunity (24 papers), Organ Transplantation Techniques and Outcomes (24 papers), Liver physiology and pathology (23 papers) and Hepatitis B Virus Studies (23 papers). The work is most often cited by research in Hepatology (4.9k citations), Epidemiology (8.6k citations), Pharmacology (1.2k citations), Endocrinology, Diabetes and Metabolism (2.0k citations) and Cell Biology (1.4k citations). Ali E. Canbay has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Gregory James Gores, Guido Gerken, Ariel E. Feldstein, Lars P. Bechmann, Jan‐Peter Sowa, Alexander Wree, Steven F. Bronk, Hajime Higuchi, Wing‐Kin Syn and Hal M. Hoffman. Their work appears in journals such as Journal of Hepatology, Digestion, Liver International, Hepatology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.